Literature DB >> 18417407

[Clearance, persistence and recurrence of HPV infection].

F Denis1, S Hanz, S Alain.   

Abstract

Cervical HPV infection is a common sexually transmitted infection. Most women are infected shortly after beginning their first relationship, with the highest prevalence seen in women under 25 years of age. Thereafter, prevalence decreases rapidly. HPV infections are usually transient; but several factors increasing persistence were identified as host factors (genetic or acquired as age, immunodepression, oral contraception, smoking) and viral factors (genotype, variants, viral load, integration...). Although it is now widely admitted that a persistent infection with a high-risk HPV type is necessary for the development of high-grade cervical intraepithelial neoplasia and invasive disease, whether persistent HPV infections are characterized by the continuing detection of HPV, or by a state of viral latency during which the virus remains undetectable only to reappear later remains unknown. The distinction between a persistent and transient infection is arbitrary depending from both the time of sampling in relation to the natural history of the infection and the interval between samples. The longitudinal studies show that "recurrent" HPV infections offer no evidence that the recurrent episode is correlated with reemergence of the same strain or another strain of the same genotype (wild or variant), but the sequential detection of other HPV type is common. The studies offer no evidence of competition between HPV types but frequently show an increased risk of acquisition of new HPV types in patients already infected compared with those who are HPV-negative.

Entities:  

Mesh:

Year:  2008        PMID: 18417407     DOI: 10.1016/j.gyobfe.2008.02.008

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  6 in total

Review 1.  A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide.

Authors:  Amy Chu; Eric Genden; Marshall Posner; Andrew Sikora
Journal:  Oncologist       Date:  2013-01-23

Review 2.  Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia.

Authors:  Kirvis Torres-Poveda; Margarita Bahena-Román; Claudia Madrid-González; Ana I Burguete-García; Víctor Hugo Bermúdez-Morales; Oscar Peralta-Zaragoza; Vicente Madrid-Marina
Journal:  World J Clin Oncol       Date:  2014-10-10

3.  Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia.

Authors:  Jingbo Wu; Xiaojing Li; Xiuping Liu; Zuhua Gao
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

4.  Vaginal Infections of Albanian women Infected with HPV and their impact in intraepithelial cervical lesions evidenced by Pap test.

Authors:  Elsa S Kone; Avenir D Balili; Piro D Paparisto; Xheladin R Ceka; Elizana D Petrela
Journal:  J Cytol       Date:  2017 Jan-Mar       Impact factor: 1.000

5.  Comparison of the novel human papillomavirus 4 auto-capillary electrophoresis test with the hybrid capture 2 assay and with the PCR HPV typing set test in the detection of high-risk HPV including HPV 16 and 18 genotypes in cervical specimens.

Authors:  Jin Hwa Hong; Seung Hun Song; Jong Kee Kim; Jeong Hyun Han; Jae Kwan Lee
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

6.  FACTORS ASSOCIATED WITH PERSISTENCE OF HPV GENITAL INFECTION IN A SMALL COHORT OF ROMANIAN WOMEN.

Authors:  Irina Huică; Iulia Virginia Iancu; Anca Botezatu; Adriana Pleşa; Demetra Socolov; Sergiu Teleman; Gabriela Anton
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.780

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.